T32 Research Post-Doc Fellow - Dr. Robert Levy Laboratory

SHIFT:
Day (United States of America)
Seeking Breakthrough Makers
Children's Hospital of Philadelphia (CHOP) offers countless ways to change lives. Our diverse community of more than 20,000 Breakthrough Makers will inspire you to pursue passions, develop expertise, and drive innovation.
At CHOP, your experience is valued; your voice is heard; and your contributions make a difference for patients and families. Join us as we build on our promise to advance pediatric care-and your career.
CHOP's Commitment to Diversity, Equity, and Inclusion
CHOP is committed to building an inclusive culture where employees feel a sense of belonging, connection, and community within their workplace. We are a team dedicated to fostering an environment that allows for all to be their authentic selves. We are focused on attracting, cultivating, and retaining diverse talent who can help us deliver on our mission to be a world leader in the advancement of healthcare for children.
We strongly encourage all candidates of diverse backgrounds and lived experiences to apply.
A Brief Overview
Dr. Robert Levy, Program Director of the National Heart, Lung and Blood Institute (NHLBI) Research Training Program affiliated with the University of Pennsylvania, Perelman School of Medicine has an opportunity for a T-32 post-doc Training in Molecular Therapeutics for Pediatric Cardiology
Note: US citizenship or permanent residency is required for this position.
The program offers training in cardiovascular research with a special emphasis on heart valve disease, serotonin receptor mechanisms, and structural degeneration of bioprosthetic valves. The program offers opportunities to train with investigators across the disciplinary spectrum of cardiovascular disease. The successful applicant will have a doctoral degree or equivalent, a record of accomplishment in research, and will be committed to a career of research related to cardiovascular disease.
Candidates should demonstrate quantitative/qualitative research skills, excellent written and oral communication skills, and the ability to work independently and with collaborators.
A track record of original first-author publications from doctoral work is desirable.
Emphasis will be placed on basic and translational research, career development, and transition toward independence.
Opportunities are available for classroom-based training and professional development in grant writing, scientific communication, and leadership.
Applicants with a Ph.D.; MD; MD-PhD with both interest and experience in basic cardiovascular research are encouraged to apply. Specific expertise in cell and molecular biology, biomaterials, bioengineering, immunology, pharmaceutics, and pharmacology is highly desired.
Please send a cover letter, curriculum vitae, names and email addresses of 3 references to:
Dr. Robert Levy Director of Cardiology Research, and William J Rashkind Chair in Pediatric Cardiology Professor of Pediatrics and Professor of Systems Pharmacology
The Perelman School of Medicine, University of Pennsylvania Children's Hospital of Philadelphia Abramson Research Center
Suite 702 3615 Civic Center Blvd
Philadelphia, PA 19104
kernss@chop.edu
Salary Information
Years of Experience
1= $65,000
2 =$66,000
3 = $66,500
4 =$67,000
Responsibilities
1. Conduct independent scholarly research and develop new methods and protocols
2. Participate in project planning, recording and evaluation of data
3. Acquire technical, lab management and grant writing skills
4. Participate in seminars, lectures, poster sessions and presentation at national meetings
5. Supervise junior lab members
6. Collaborate with other research projects
To carry out its mission, CHOP is committed to supporting the health of our patients, families, workforce, and global community. As a condition of employment, CHOP employees who work in patient care buildings or who have patient facing responsibilities must be fully vaccinated against COVID-19 and receive an annual influenza vaccine. Learn more.
Employees may request exemptions for valid religious and medical reasons. Start dates may be delayed until candidates are immunized or exemption requests are reviewed.
EEO / VEVRAA Federal Contractor | Tobacco Statement